emergency department evaluation and management of the febrile traveler
TRANSCRIPT
![Page 1: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/1.jpg)
Fever in the International Traveler
Resident Conference
Joseph M Reardon, MD
![Page 2: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/2.jpg)
Disclosure Statement
• No financial conflicts of interest to disclose.
Special Thanks• Paul Lantos, MD
![Page 3: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/3.jpg)
![Page 4: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/4.jpg)
Your best friend for travel medicine:
![Page 5: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/5.jpg)
Color Codes
•Red = Core EM Content
•Black = All the fun stuff
![Page 6: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/6.jpg)
Background: Travel Medicine
•100,000 international travelers per year
•50,000 have a health problem while traveling
•8,000 will see a physician
•1,100 will be incapacitated (i.e., our patients)ISTM
![Page 7: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/7.jpg)
Case
• PWR
• 45y M
• No PMH
• 3d fever to 102F, chills, sweats
• Mild generalized HA
• NBNB emesis x1
• Malaise
• ROS otherwise negative
collider.com
![Page 8: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/8.jpg)
Travel Screening!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
![Page 9: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/9.jpg)
![Page 10: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/10.jpg)
![Page 11: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/11.jpg)
Guinea-Bissau: 0 cases
Guinea: 2,871 cases
![Page 12: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/12.jpg)
Approach to Febrile Traveler
• Travel History• Countries
• Dates
• Setting (urban vs rural)
• Contacts
• Vaccination Status
• S/Sx
• ROS
PLOS Neglected Tropical Diseases
![Page 13: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/13.jpg)
Differential Diagnosis
![Page 14: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/14.jpg)
Malariarealsimplescience.com
![Page 15: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/15.jpg)
Malaria: Location300-500 million infections/yr; 2.5 million deaths/yr
![Page 16: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/16.jpg)
Malaria: Life Cycle
![Page 17: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/17.jpg)
Malaria: Causative agent
CDC
![Page 18: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/18.jpg)
Malaria: Risk Factors
ISTM
• Travel to Africa:• 2.4% risk per month in West Africa
• 1.5% risk per month in East Africa
• Mosquito exposure (Anopheles gambiae vs Anopheles quadrangulatus)• Day biting (Haiti, much of Latin America) vs
• Night biting (Africa)
• 90% of reported cases in travelers had symptom onset after return to North America
![Page 19: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/19.jpg)
Malaria: Symptoms
• Cyclical fever / chills / sweats• (often absent for falciparum, variable for others)
• Tachycardia, tachypnea
• Headache
• Cough
• Nausea / vomiting / abdominal pain / diarrhea / anorexia
• Arthralgias / myalgias
• Initial symptoms are often misleading!
WHO
![Page 20: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/20.jpg)
• Vitals
• Skin: • Jaundice
• +/- anemia
• Splenomegaly (more common after several days)
• Hepatomegaly
Malaria: Physical Exam
![Page 21: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/21.jpg)
• CBC: normochromic, normocytic anemia, thrombocytopenia
• CMP: hypoglycemia, mild transaminitis
• Coags
• T&S
• Rapid test
• Giemsa Stain: thick and thin smears
• UA
• CXR
• CT Abd if splenic infarct is suspected
• NOTE: RPR and VDRL may be falsely positive!
Malaria: Diagnostic Testing
Binax
![Page 22: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/22.jpg)
Malaria: Treatment
• By region:• Chloroquine-sensitive regions (including Mexico): chloroquine
• Nonendemic areas (i.e., short-term travelers): atovaquone-proguanil(Malarone) or mefloquine (contraindicated in Long QT)• Alternative: primaquine (but must test for G6PD first to avoid fatal hemolysis!!)
• Endemic areas (i.e., long-term travelers / native residents): Artemisinincombination therapy (ex: Artemether-lumefantrine [Coartem])
• Supportive care (fluids, antipyretics, antiemetics)
• Consider exchange transfusion if signs of end-organ damage
First Aid
![Page 23: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/23.jpg)
• Diagnoses of complicated malaria must be admitted to ICU• AMS, seizures
• Respiratory / circulatory collapse
• Metabolic acidosis
• Renal failure, hemoglobinuria, jaundice (blackwater fever)
• Hepatic failure
• Coagulopathy, DIC
• Severe anemia (>5% of RBCs with parasites, OR >100,000 parasites / mcL)
• Hypoglycemia
• Pregnant patient: high risk for placental malaria
Malaria: Critical Actions
![Page 24: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/24.jpg)
TyphoidTelugumd.com
![Page 25: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/25.jpg)
Typhoid: Location
Frontiersoftravel.com
![Page 26: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/26.jpg)
Typhoid: Life Cycle
Causes:
• Salmonella typhiTyphoid
• Salmonella paratyphiParatyphoid (types A, B & C)• A & B are indistinguishable
from typhoid
• C has different symptomatology
![Page 27: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/27.jpg)
Typhoid: History and Physical Exam• Week 1: (in unvaccinated)
• Gradually rising (“stepwise”) fever, chills, without rigors• Relative bradycardia• Diarrhea OR constipation• Headache
• Week 2:• Abd pain• “Rose spots” (faint salmon-colored macules on trunk & abdomen)
• Week 3:• Intestinal bleeding• Intestinal perforation, sepsis, peritonitis• Septic shock (15% of cases)• AMS (17% of cases)• DIC, pneumonia, meningitis, myocarditis, renal failure
Lisa See
![Page 28: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/28.jpg)
Typhoid: Diagnostic Testing
• CBC
• CMP
• Coags
• Stool culture (30% sensitive but very specific)
• Blood cultures x2 (70% sensitive but very specific)
• The floor may obtain bone marrow culture (gold standard) or ELISA
![Page 29: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/29.jpg)
Typhoid: Treatment
• Patients from Asia: azithro
• Rest of the world: Cipro• Alternative: ceftriaxone 2g IV/IM x 2 wks
• Recognize need for blood transfusion
HippoEM
![Page 30: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/30.jpg)
Typhoid: Critical Actions
•Recognize life-threatening complications:• Typhoid encephalopathy: AMS (17% of pts)
• Treatment: dexamethasone
• Intestinal perforation (more common in small bowel)(10-25% of pts)
• DIC
Tintinalli
![Page 31: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/31.jpg)
DengueVirology.wisc.edu
![Page 32: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/32.jpg)
Dengue: Location
WHO
100 million infections/yr; 25,000 deaths/yr
![Page 33: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/33.jpg)
Dengue: Life Cycle
Oxitec.comSingapore MOH
Four serotypes
Arbovirus (=Arthropod-borne virus)
![Page 34: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/34.jpg)
Dengue: Symptoms
• “breakbone fever” x 5-7d• sometimes biphasic fever with a second 1-2d period
• Myalgias, arthralgias
• Retroorbital HA
• N/V (1/2 of pts), diarrhea (1/3 of pts)
• Dry cough, sore throat, congestion (1/3 of pts)
• More likely asymptomatic in children
First Aid
![Page 35: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/35.jpg)
Dengue: Physical Exam• “Dengue facies” with facial edema
• Fever
• Nonspecific exam
• Pale, morbilliform rash in ½ of pts• Spreads from trunk outward to extremities/face
• Up to ½ of pts with:• Conjunctival injection• Pharyngeal erythema• Lymphadenopathy• Hepatomegaly
UTD
![Page 36: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/36.jpg)
Dengue: Diagnostic Testing
• Dengue ELISA
• CBC• Leukopenia is specific to the diagnosis
• Thrombocytopenia <100k in most pts
• CMP• Mild AST elevation (2-5 times upper limit of normal)
• T&S
• Fibrinogen
![Page 37: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/37.jpg)
Dengue: Critical Actions• Diagnosing Dengue Hemorrhagic Fever
• Typically an autoimmune-mediated phenomenon in patients with prior dengue infection
• Four cardinal features:• Hemoconcentration (Hct >20% above baseline)
• Plt <100k
• Fever x2-7d
• Hemorrhage• Positive tourniquet test
• Spontaneous bleeding
• Require ICU admission
• Shock of septic & hemorrhagic origin
• 50% mortality without care; <5% mortality with careFirst Aid
![Page 38: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/38.jpg)
Tourniquet Test
• 6:27-6:37
• Inflate BP cuff to MAP x 5 mins
• Inspect for petechiae
CDC
![Page 39: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/39.jpg)
Dengue: Treatment
• Fever management with APAP• Avoid aspirin and NSAIDs due to bleeding
risk
• DIC Management
• Aggressive fluid resuscitation for vascular permeability
• No indication for steroids, antivirals, etc.
Williams’ Hematology
![Page 40: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/40.jpg)
…AND??? …AND???
Fever + Headache in a traveler =
Malaria, dengue, meningitis…
![Page 41: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/41.jpg)
Chikungunya Virus
CDC
![Page 42: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/42.jpg)
Chiku-what???
![Page 43: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/43.jpg)
![Page 44: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/44.jpg)
Chikungunya: Location
NYTimes.com
2nd most common arbovirus in travelers, after Dengue
![Page 45: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/45.jpg)
Chikungunya: Life Cycle
PLOS Neglected Tropical Diseases
![Page 46: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/46.jpg)
• High fever x3-5d
• Symmetrical (70%) polyarthralgia, primarily distal (60%)
• Occasionally, meningoencephalitis
• Rarely, ascending paralysis & Guillain-Barré
Chikungunya: Symptoms
Tintinalli
![Page 47: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/47.jpg)
Chikungunya: Physical Exam
•Periarticular edema
•Rash starting after 3d starting peripherally
Intl Congress on Infectious Diseases
![Page 48: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/48.jpg)
Chikungunya: Diagnosis
• Chikungunya IgM ELISA
• PCR
• CBC
• CMP
• EKG
• Consider LP to r/o alternative cause of neurologic manifestation
• No quick diagnostic mechanism!
Tintinalli
![Page 49: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/49.jpg)
Chikungunya: Treatment
•NSAIDs once dengue fever is ruled out
•Ribavirin for severe cases
• Interferon-alpha for severe cases
•Chloroquine may reduce long-term arthralgias (but is not recommended by most recent studies)
Tintinalli
![Page 50: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/50.jpg)
Chikungunya: Red Flags
• Meningoencephalitis is most common neurologic complication
• Respiratory failure
• Myocarditis
• Shock
• 5-30% of patients will have chronic arthropathy
• Severe complications are rare.
![Page 51: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/51.jpg)
N. Meningitidis Serotype A
BioQuell
![Page 52: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/52.jpg)
Neisseria meningitidis Serotype A: Location
Natl Healthcare Travel Network & Centre
![Page 53: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/53.jpg)
Neisseria meningitidis Serotype A: Pearls
• Slightly different serotype from N. meningitidis in the United States, which contributes to its high transmissibility
• Is preventable with Menactra and Menveo vaccines
• A new vaccine is being developed specifically targeted for the African strain
• Treat similarly to US-acquired meningitis:• Ceftriaxone admit to monitored setting
• Strains generally respond to ceftriaxone and even penicillin G!
![Page 54: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/54.jpg)
ComparisonAgent P. falciparum S. typhi Dengue virus Chikungunya
Location Tropics Tropics Tropics Africa,Asia,Euro,Carribbean
Key Symptoms Cyclic fever Abd pain, IBS-likesymptoms
Retroorbital HA Polyarthralgias, rash
Exam Findings Splenomegaly Rose spots Petechiae Edema, rash
Diagnosis Giemsa BCx, Stool Cx Coaguloathy, ELISA Transaminitis, ELISA
Treatment Chloroquine,atovaquone, artemisinin
Azithro (Asia), Cipro (everyone else)
Supportive, transfusion
Supportive, ribavirin, interferon
Red Flags Cerebral malaria, Placental malaria
Encephalopathy, intestinal perf
Dengue Hemorrhagic Fever
Meningoencephalitis
![Page 55: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/55.jpg)
Practice questions!A 4-year-old female Brazilian immigrant presents with fatigue and abdominal pain with temperature to 104F. She appears acutely ill. She is tachycardic and tachypneic with hepatomegaly; there is no rash or indication of joint pain. Test results include: Tbili 4.9, AST 236, ALT 247. RUQ ultrasound demonstrates an enlarged liver.
• Which would confirm the diagnosis?• Viral hepatitis panel
• Blood smear
• Leptospirosis microscopic agglutination test
• Stool O&P
Modified from PEER
![Page 56: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/56.jpg)
Practice questions!A 27-year-old male backpacker presents with diffuse macular erythrodermal rash, blood pressure 85/37, temperature 102F. Lab tests reveal elevated transaminases and creatinine, and Plt of 86K. He recently returned from Guatemala and states that he developed a persistent nosebleed while hiking 1 week ago. He still has packing in both nostrils.
• What is the most likely causative agent?• Rickettsia prowazekii
• Dengue virus
• Staphylococcus aureus
• Yersinia pestis
Modified from PEER
![Page 57: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/57.jpg)
Practice questions!A 24-year-old man presents with high fever to 106F, confusion, swelling of the wrists and ankles, and weakness of the bilateral lower extremities. He recently traveled to Democratic Republic of Congo and received all recommended vaccinations prior to travel. Which of the following is most likely to reduce the risk of neurologic complication?
• Ice packs and intravenous ketorolac 30mg Q6H
• Ice packs, intravenous acetaminophen, and await serologic testing
• Lumbar puncture and therapeutic CSF removal
• Intravenous piperacillin/tazobactam
• Intravenous methylprednisolone
![Page 58: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/58.jpg)
Practice questions!A 39-year-old woman presents with confusion, mild headache, generalized myalgias, and morbiliform rash in the setting of 2 weeks of low-grade fever. She returned from Peru last week. She has been constipated since she returned home, which she attributes to no longer eating vegetables from roadside stands. Which of the following is most important to prevent serious neurologic complication?
• Intravenous azithromycin
• Intravenous ciprofloxacin and dexamethasone
• Intravenous vancomycin and piperacillin/tazobactam
• Intravenous acyclovir
![Page 59: Emergency Department Evaluation and Management of the Febrile Traveler](https://reader034.vdocuments.mx/reader034/viewer/2022042716/55aa86441a28abb4358b4719/html5/thumbnails/59.jpg)